Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16180685 | 0.76 | NOTUM (0.48) | NOTUM | |
| SCHEMBL9624552 | 0.71 | ALDH1A1 (0.32) | — | |
| SCHEMBL6505405 | 0.66 | NOTUM (0.52) | NOTUM | |
| SCHEMBL11881630 | 0.64 | TSHR (0.31) | — | |
| SCHEMBL29509555 | 0.62 | NOTUM (0.38) | NOTUM | |
| SCHEMBL6563967 | 0.62 | ALDH1A1 (0.39) | NOTUM | |
| SCHEMBL17709972 | 0.62 | NOTUM (0.38) | NOTUM | |
| SCHEMBL12479120 | 0.62 | NOTUM (0.43) | NOTUM | |
| SCHEMBL21839969 | 0.62 | CYP3A4 (0.55) | NOTUM | |
| SCHEMBL7124314 | 0.61 | NOTUM (0.52) | NOTUM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7384749-B2 | Electrodes linked via conductive oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. (US) | 2008-06-10 | — | — | US | disclosed |
| US-7381533-B2 | Electrodes linked via oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. (US) | 2008-06-03 | — | — | US | disclosed |
| US-7381525-B1 | AC/DC voltage apparatus for detection of nucleic acids | CLINICAL MICRO SENSORS, INC. (US) | 2008-06-03 | — | — | US | disclosed |
| US-7125668-B2 | Electrodes linked via conductive oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. (US) | 2006-10-24 | — | — | US | disclosed |
| US-20060211016-A1 | Electrodes linked via conductive oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. | 2006-09-21 | — | — | US | disclosed |
| US-7056669-B2 | AC methods for the detection of nucleic acids | CLINICAL MICRO SENSORS, INC. (US) | 2006-06-06 | — | — | US | disclosed |
| US-7045285-B1 | Electronic transfer moieties attached to peptide nucleic acids | CLINICAL MICRO SENSORS, INC. (US) | 2006-05-16 | — | — | US | disclosed |
| US-20060099631-A1 | Electrodes linked via oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. | 2006-05-11 | — | — | US | disclosed |
| US-7014992-B1 | Conductive oligomers attached to electrodes and nucleoside analogs | CLINICAL MICRO SENSORS, INC. (US) | 2006-03-21 | — | — | US | disclosed |
| US-6977151-B2 | Electrodes linked via conductive oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. (US) | 2005-12-20 | — | — | US | disclosed |
| US-20030150723-A1 | Electrodes linked via conductive oligomers to nucleic acids | ROCHE MOLECULAR SYSTEMS, INC. | 2003-08-14 | — | — | US | disclosed |
| US-20030148328-A1 | AC methods for the detection of nucleic acids | ROCHE MOLECULAR SYSTEMS, INC. | 2003-08-07 | — | — | US | disclosed |
| US-20030003473-A1 | Electrodes linked via conductive oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. | 2003-01-02 | — | — | US | disclosed |
| US-6479240-B1 | Electrodes linked via conductive oligomers to nucleic acids | CLINICAL MICRO SENSORS, INC. | 2002-11-12 | — | — | US | disclosed |
| US-6221583-B1 | USE OF NUCLEIC ACIDS CONTAINING ELECTRON TRANSFER MOIETIES TO BE USED AS NUCLEIC ACID PROBES; PROBE NUCLEIC ACID IS COVALENTLY ATTACHED TO AN ELECTRODE VIA A CONDUCTIVE OLIGOMER | CLINICAL MICRO SENSORS, INC. | 2001-04-24 | — | — | US | disclosed |
| US-6096273-A | SITE-SELECTIVE MODIFICATION OF NUCLEIC ACIDS WITH ELECTRON TRANSFER MOIETIES AND ELECTRODES, FOR GENE PROBES, MEDICAL DIAGNOSIS, TISSUE COMPATIBILITY EVALUATIONS BEFORE TRANSPLANTATION, FORENSICS | CLINICAL MICRO SENSORS (US) | 2000-08-01 | — | — | US | disclosed |
| US-6090933-A | ATTACHING THE SULFUR OF A CONDUCTIVE OLIGOMER HAVING A FIRST SUBUNIT OF A SULFUR ATOM PROTECTED BY ETHYL PYRIDINE OR TRIMETHYLSILYL ETHYL, TO THE GOLD ELECTRODE; NUCLEIC ACIDS COVALENTLY COUPLED TO ELECTRODES VIA CONDUCTIVE OLIGOMERS | CLINICAL MICRO SENSORS, INC. (US) | 2000-07-18 | — | — | US | disclosed |
| US-6063573-A | SINGLE-STRANDED PROBE FOR SCREENING TARGET NUCLEOTIDE SEQUENCES | CLINICAL MICRO SENSORS, INC. (US) | 2000-05-16 | — | — | US | disclosed |
| EP-0939762-A2 | ELECTRODES LINKED VIA CONDUCTIVE OLIGOMERS TO NUCLEIC ACIDS | Clinical Micro Sensors (US) | 1999-09-08 | — | — | EP | disclosed |
| WO-1998020162-A2 | ELECTRODES LINKED VIA CONDUCTIVE OLIGOMERS TO NUCLEIC ACIDS | CLINICAL MICRO SENSORS (US) | 1998-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060099631-A1 | Electrodes linked via oligomers to nucleic acids | POLRMT, APEX1, MTREX | NOTUM 4540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.